Die Asthmakontrolle bei Erwachsenen und Kindern muss optimiert werden!

Zusammenfassung

Entsprechend der GINA-Kriterien ist es Ziel des Asthma-Managements, eine optimale Symptomkontrolle zu erreichen und die Risiken für Exazerbationen, Verschlechterungen der Lungenfunktion, Langzeitfolgen und Nebenwirkungen der Therapie zu minimieren. Studien wie REALISE und AIRE geben uns Informationen dahingehend, ob und wie sich innerhalb von annähernd 15 Jahren Verbesserungen bei der Versorgung von Patienten mit Asthma bronchiale eingestellt haben. Obwohl es sehr wirksame Medikamente zur Behandlung des Asthma bronchiale gibt, sind die Ergebnisse der Asthmakontrolle weiterhin unbefriedigend. Bei deutlich mehr als 50 % der Patienten muss das Asthma als nicht bzw. schlecht kontrolliert angesehen werden. Eine schlechte Therapieadhärenz, die Angst vor systemischen Effekten der inhalativen Kortisontherapie, die vermehrte Inanspruchnahme der Bedarfstherapie, eine nicht ausreichende Schulung und Aufklärung der Patienten sind dafür verantwortlich. Es besteht eine Notwendigkeit zur Intensivierung der Schulungsmaßnahmen und verbesserten Patientenüberwachung.

Abstract

Medication management of asthma is based on level of asthma control. GINA defined criteria for asthma control include asking about daytime symptoms, limitation of activity, nocturnal symptoms/awakenings and need for reliever treatment. Effective asthma control is necessary for preventing exacerbations and worsening of lung function. Standardized and validated questionnaires such as asthma control test (ACT) help to assess the level of asthma control. Asthma control is classified as controlled, partially controlled or uncontrolled. Multicenter studies like REALISE and AIRE give health care professionals information about effectiveness and adherence to medication over nearly 15 years. Asthma is still poorly controlled in more than 50 % of patients despite the availability of very effective drugs. Low adherence to the treatment, fear of systemic side effects related to long term treatment with inhaled corticosteroids, inadequate knowledge of the disease may be responsible factors for bad asthma control. Optimized tools for disease management and intensified education are necessary for therapeutic success.

• Literatur

• 1 Global Initiative for Asthma Management and Prevention. Guideline (GINA). www.ginasthma.org
• 2 Buhl R, Bals R, Baur X. et al. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. Pneumologie 2017; 71: 849-919
• 3 Rabe KF, Vermeire PA, Soriano JB. et al. Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807
• 4 Price D, Fletcher M, van der Molen T. Asthma control and management in 8000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. Primary Care Respiratory Medicine 2014; 24: 14009
• 5 Olaguibel JM, Quirce S, Julia B. et al. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire. Respiratory Research 2012; 13: 50
• 6 Caminati M, Bettoncelli G, Magnoni MS. et al. The level of control of mild asthma in general practice: an observational community-based study. J Asthma 2014; 51: 91-96
• 7 Nathan RA, Thompson PJ Price D. et al. Taking Aim at Asthma Around The World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States. J Allergy Clin Immunol Pract 2015; 3: 734-742
• 8 Woodcock A, Vestbo J, Bakerly ND. et al. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomized controlled trial. Lancet 2017; 390: 2247-2255
• 9 Caminati M, Senna G, Segala N. et al. Evaluation of asthma control in the pharmacy: an Italian cross-sectional study. Eur Ann Allergy Clin Immunol 2017; 49: 225-230
• 10 Chapman KR, Hinds D, Piazza P. et al. Physician perspectives on the burden and management of asthma in six countries: The Global Asthma Physician Survey (GAPS). BMC Pulmonary Medicine 2017; 17: 153
• 11 Sears MR. Trends in the prevalence of asthma. Chest 2014; 145: 219-225
• 12 Nathan RA. et al. Development of the asthma control test: A survey for assessing asthma control. J. Allergy Clin. Immunol 2004; 113: 59-65
• 13 Rubin BK, Zhao W, Winders TA. What do patients want from their asthma care doctors?. Pediatric Respiratory Reviews 2017; DOI: 10.1016/j.prrv.2017.11.002.
• 14 Fletcher M, Hiles D. Continuing discrepancy between patient perception of asthma control and real-world symptoms: a quantitative online survey of 1083 adults with asthma from the UK. Prim Care Respir J 2013; 22: 431-438
• 15 Schauerte G, Weber A, Umpfenbach U. DMP Asthma bronchiale – erfolgreich bei Kindern und Jugendlichen. In: Steiss JO. Hrsg. Ambulante pädiatrische Pneumologie. Oberhaching-München: Dustri Verlag; 2018
• 16 Basiswissen DMP. DMP erfolgreich umsetzen. Asthma bronchiale und COPD. Berlin: AOK Bundesverband; 2017
• 17 Hagen B, Altenhofen L, Groos S. et al. Qualitätsicherungsbericht 2014 Disease-Management-Programme in Nordrhein (Kapitel 91): DMP Asthma bronchiale. Hrsg: Nordrheinische Gemeinsame Einrichtung Disease-Management-Programme GbR
• 18 Steppuhn H, Langen U, Mueters S. et al. Asthma management practices in adults – findings from the German Health Update (GEDA) 2010 and the German National Health Interview and Examination Survey (DEGS1) 2008–2011. J Asthma 2016; 53: 50-61
• 19 Gold LS, Smith N, Allen-Ramey FC. et al. Association of patient outcomes with level of asthma control. Ann Allergy Asthma Immunol 2012; 109: 260-265
• 20 Ding B, Small M. Disease Burden of Mild Asthma: Findings from a Cross-Sectional Real-World Survey. Adv Ther 2017; 34: 1109-1127
• 21 Banasiak NC. Understanding the Relationship between Asthma and Sleep in the Pediatric Population. J Pediatr Health Care 2016; 30: 546-550
• 22 Khan WH, Mohsenin V, D’Ambrosio CM. Sleep in Asthma. Clin Chest Med 2014; 35: 483-493
• 23 Desager KN, Nelen V, Weyler JJ. et al. Sleep disturbances and daytime symptoms in wheezing school-aged children. J Sleep Res 2005; 14: 77-82
• 24 Diette GB, Markson L, Skinner EA. et al. Nocturnal asthma in children affects school attendance, school performance, and parents’ work attendance. Arch Pediatr Adolesc Med 2000; 154: 923-928
• 25 Nilsson S, Ödlin M, Andersson N. et al. Does asthma affect school performance in adolescents? Results from the Swedish population-based birth cohort BAMSE. Pediatr Allergy Immunol 2018; 29: 174-179
• 26 Lozier MJ, Zahran HS, Bailey CM. Assessing health outcomes, quality of life, and healthcare use among school-age children with asthma. J Asthma 2018; 9: 1-8
• 27 Koehler U, Brandenburg U, Weissflog A. et al. LEOSound, an innovative procedure for acoustic long-term monitoring of asthma symptoms (wheezing and coughing) in children and adults. Pneumologie 2014; 68: 277-281
• 28 Koehler U, Hildebrandt O. Hrsg. Atem- und Atemnebengeräusche bei Kindern und Erwachsenen – Akustische Langzeitregistrierung und -analyse. Bremen-London-Boston: UNI-MED Verlag; 2017
• 29 Krönig J, Hildebrandt O, Weissflog A. et al. Long-term Recording of Night-Time Respiratory Symptoms in Patients with Stable COPD II–IV. COPD 2017; 14: 498-503
• 30 Guenter K, Cassel W, Hildebrandt O. et al. Control of respiratory symptoms during sleep in patients with stable bronchial asthma. DMW. [in press]